Study title:
Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):13-21. Epub 2005 Sep 9.
Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence
of surgically treated non-small cell lung cancer.
Hellwig D, GrÃschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht
GW, Kirsch CM.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|